Literature DB >> 22215837

A 46-year-old man with seizures, brain lesions, and pulmonary infiltrates.

Rachel L Zemans1, Amanda R Stream2, Ali I Musani3, Gurpreet Dhaliwal4.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22215837      PMCID： PMC3251270          DOI： 10.1378/chest.11-1397

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  10 in total

Review 1.  Pulmonary alveolar proteinosis.

Authors:  Bruce C Trapnell; Jeffrey A Whitsett; Koh Nakata
Journal:  N Engl J Med       Date:  2003-12-25       Impact factor: 91.245

2.  Pulmonary alveolar proteinosis.

Authors:  S H ROSEN; B CASTLEMAN; A A LIEBOW
Journal:  N Engl J Med       Date:  1958-06-05       Impact factor: 91.245

3.  Pulmonary alveolar proteinosis associated with dust inhalation: not secondary but autoimmune?

Authors:  Ulrich Costabel; Koh Nakata
Journal:  Am J Respir Crit Care Med       Date:  2010-03-01       Impact factor: 21.405

4.  Nocardial infection of the pulmonary and central nervous system: successful treatment with medical therapy.

Authors:  J Viroslav; T W Williams
Journal:  South Med J       Date:  1971-11       Impact factor: 0.954

5.  Primary cerebellar nocardiosis and alveolar proteinosis.

Authors:  W G Oerlemans; E N Jansen; R L Prevo; M M Eijsvogel
Journal:  Acta Neurol Scand       Date:  1998-02       Impact factor: 3.209

6.  Inhaled granulocyte/macrophage-colony stimulating factor as therapy for pulmonary alveolar proteinosis.

Authors:  Ryushi Tazawa; Bruce C Trapnell; Yoshikazu Inoue; Toru Arai; Toshinori Takada; Yasuyuki Nasuhara; Nobuyuki Hizawa; Yasunori Kasahara; Koichiro Tatsumi; Masayuki Hojo; Haruyuki Ishii; Masanori Yokoba; Naohiko Tanaka; Etsuro Yamaguchi; Ryosuke Eda; Yoshiko Tsuchihashi; Konosuke Morimoto; Masanori Akira; Masaki Terada; Junji Otsuka; Masahito Ebina; Chinatsu Kaneko; Toshihiro Nukiwa; Jeffrey P Krischer; Kohei Akazawa; Koh Nakata
Journal:  Am J Respir Crit Care Med       Date:  2010-02-18       Impact factor: 21.405

7.  [A case of pulmonary alveolar proteinosis with increased IgE and CEA].

Authors:  M Higuchi; Y Kawarada; T Nishio; M Takii; H Okubo
Journal:  Nihon Kyobu Shikkan Gakkai Zasshi       Date:  1994-03

Review 8.  Pulmonary alveolar phospholipoproteinosis: experience with 34 cases and a review.

Authors:  U B Prakash; S S Barham; H A Carpenter; D E Dines; H M Marsh
Journal:  Mayo Clin Proc       Date:  1987-06       Impact factor: 7.616

Review 9.  The medically important aerobic actinomycetes: epidemiology and microbiology.

Authors:  M M McNeil; J M Brown
Journal:  Clin Microbiol Rev       Date:  1994-07       Impact factor: 26.132

Review 10.  Pulmonary alveolar proteinosis: progress in the first 44 years.

Authors:  John F Seymour; Jeffrey J Presneill
Journal:  Am J Respir Crit Care Med       Date:  2002-07-15       Impact factor: 21.405
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.